Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles